The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer
Open accessAbstract
BACKGROUND: Growing evidence supports cognitive dysfunction associated with standard dose chemotherapy in breast cancer survivors. We determined the incidence, nature, and chronicity of cognitive dysfunction in a prospective longitudinal randomized phase 3 treatment trial for patients with T1‐3, N0‐1, M0 breast cancer receiving 5‐fluorouracil, doxorubicin, and cyclophosphamide with or without paclitaxel. METHODS: Forty‐two patients underwent a neuropsychological evaluation including measures of cognition, mood, and quality of life. Patients were scheduled to be assessed before chemotherapy, during and shortly after chemotherapy, and 1 year after completion of chemotherapy. RESULTS: Before chemotherapy, 21% (9 of 42) evidenced cognitive dysfunction. In the acute interval, 65% (24 of 37) demonstrated cognitive decline. At the long‐term evaluation, 61% (17 of 28) evidenced cognitive decline after cessation of treatment. Within this group of patients, 71% (12 of 17) evidenced continuous decline from the acute interval, and, notably, 29% (5 of 17) evidenced new delayed cognitive decline. Cognitive decline was most common in the domains of learning and memory, executive function, and processing speed. Cognitive decline was not associated with mood or other measured clinical or demographic characteristics, but late decline may be associated with baseline level of performance. CONCLUSIONS: Standard dose systemic chemotherapy is associated with decline in cognitive function during and shortly after completion of chemotherapy. In addition, delayed cognitive dysfunction occurred in a large proportion of patients. These findings are consistent with a developing body of translational animal research demonstrating both acute and delayed structural brain changes as well as functional changes associated with common chemotherapeutic agents such as 5‐flouorouracil. Cancer 2010. © 2010 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jacobson, N. S., & Truax, P. (1991) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.59.1.12 · Cited by 7,770
What is cognitive reserve? Theory and research application of the reserve concept
STERN, Y. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617702813248 · Cited by 3,951
Spielberger, C. D. (2010) · The Corsini Encyclopedia of Psychology · doi:10.1002/9780470479216.corpsy0943 · Cited by 2,535
Cancer: Principles and Practice of Oncology.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-506_5 · Cited by 1,900
Brady, M. J., Cella, D. F., Mo, F., Bonomi, A. E., Tulsky, D. S., Lloyd, S. R., Deasy, S., Cobleigh, M., & Shiomoto, G. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.974 · Cited by 1,752
Benedict, R. H. B., Schretlen, D., Groninger, L., & Brandt, J. (1998) · The Clinical Neuropsychologist · doi:10.1076/clin.12.1.43.1726 · Cited by 1,597
The hopkins verbal learning test: Development of a new memory test with six equivalent forms
Brandt, J. (1991) · Clinical Neuropsychologist · doi:10.1080/13854049108403297 · Cited by 1,317
Multilingual Aphasia Examination
Patterson, J. P. (2018) · Encyclopedia of Clinical Neuropsychology · doi:10.1007/978-3-319-57111-9_900 · Cited by 1,096
van Dam, F. S. A. M., Boogerd, W., Schagen, S. B., Muller, M. J., Droogleever Fortuyn, M. E., Wall, E. V. D., & Rodenhuis, S. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.3.210 · Cited by 763
Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20272 · Cited by 679
Self-citationBenton controlled oral word association test: Reliability and updated norms
Ruff, R. (1996) · Archives of Clinical Neuropsychology · doi:10.1016/0887-6177(95)00033-x · Cited by 617
Individual change after epilepsy surgery: Practice effects and base-rate information.
Chelune, G. J., Naugle, R. I., Lüders, H., & Sedlak, J. (1993) · Neuropsychology · doi:10.1037//0894-4105.7.1.41 · Cited by 597
Dietrich, J., Han, R., Yang, Y., Mayer-Pröschel, M., & Noble, M. (2006) · Journal of Biology · doi:10.1186/jbiol50 · Cited by 500
DIKMEN, S. S., HEATON, R. K., GRANT, I., & TEMKIN, N. R. (1999) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617799544056 · Cited by 473
Jenkins, V, Shilling, V, Deutsch, G., Bloomfield, D., Morris, R., Allan, S., Bishop, H., Hodson, N., Mitra, S., Sadler, G., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603029 · Cited by 407
Hermelink, K., Untch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., & Münzel, K. (2007) · Cancer · doi:10.1002/cncr.22610 · Cited by 356
Cognitive function in breast cancer patients prior to adjuvant treatment
Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., Hanscom, B. S., Mulrooney, T. J., Schwartz, G. N., & Kaufman, P. A. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9686-5 · Cited by 345
‘Chemobrain’ in breast carcinoma?: A prologue
Wefel, J. S., Lenzi, R., Theriault, R., Buzdar, A. U., Cruickshank, S., & Meyers, C. A. (2004) · Cancer · doi:10.1002/cncr.20393 · Cited by 334
Self-citationDetecting significant change in neuropsychological test performance: A comparison of four models
TEMKIN, N. R., HEATON, R. K., GRANT, I., & DIKMEN, S. S. (1999) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617799544068 · Cited by 324
Cognitive impairment associated with adjuvant therapy in breast cancer
Bender, C. M., Sereika, S. M., Berga, S. L., Vogel, V. G., Brufsky, A. M., Paraska, K. K., & Ryan, C. M. (2006) · Psycho-Oncology · doi:10.1002/pon.964 · Cited by 320
Han, R., Yang, Y. M., Dietrich, J., Luebke, A., Mayer-Pröschel, M., & Noble, M. (2008) · Journal of Biology · doi:10.1186/jbiol69 · Cited by 316
Practice effects during repeated administrations of memory tests with and without alternate forms
Benedict, R. H. B., & Zgaljardic, D. J. (1998) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.20.3.339.822 · Cited by 304
Schagen, S. B., Muller, M. J., Boogerd, W., Mellenbergh, G. J., & van Dam, F. S. A. M. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj470 · Cited by 295
McSweeny, A. J., Naugle, R. I., Chelune, G. J., & Lüders, H. (1993) · Clinical Neuropsychologist · doi:10.1080/13854049308401901 · Cited by 269
Hurria, A., Rosen, C., Hudis, C., Zuckerman, E., Panageas, K. S., Lachs, M. S., Witmer, M., Van Gorp, W. G., Fornier, M., D'Andrea, G., et al. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00732.x · Cited by 264
Neurological complications of radiotherapy and chemotherapy
Keime-Guibert, F., Napolitano, M., & Delattre, J.-Y. (1998) · Journal of Neurology · doi:10.1007/s004150050271 · Cited by 246
Buzdar, A. U., Singletary, S. E., Theriault, R. L., Booser, D. J., Valero, V., Ibrahim, N., Smith, T. L., Asmar, L., Frye, D., Manuel, N., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3412 · Cited by 242
Self-citationIngraham, L. J., & Aiken, C. B. (1996) · Neuropsychology · doi:10.1037//0894-4105.10.1.120 · Cited by 234
Crandall, J., Sakai, Y., Zhang, J., Koul, O., Mineur, Y., Crusio, W. E., & McCaffery, P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306336101 · Cited by 213
Shilling, V., Jenkins, V., Morris, R., Deutsch, G., & Bloomfield, D. (2005) · The Breast · doi:10.1016/j.breast.2004.10.004 · Cited by 208
The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice
WINOCUR, G., VARDY, J., BINNS, M., KERR, L., & TANNOCK, I. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.07.010 · Cited by 193
Cognitive impairments associated with breast cancer treatments: results from a longitudinal study
Quesnel, C., Savard, J., & Ivers, H. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0114-2 · Cited by 182
Takimoto, C. H. M., Lu, Z. H., Zhang, R., Liang, M. D., Larson, L., Cantilena, L. R., Grem, J. L., Allegra, C. J., Diasio, R. B., & Chu, E. (1996) · PubMed · Cited by 164
The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study
Stewart, A., Collins, B., MacKenzie, J., Tomiak, E. M., Verma, S., & Bielajew, C. H. (2007) · Psycho-Oncology · doi:10.1002/pon.1210 · Cited by 155
Wilson, B. A., Watson, P., Baddeley, A., Emslie, H. C., & Evans, J. J. (2000) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617700644053 · Cited by 153
Levine, A. J., Miller, E. N., Becker, J. T., Selnes, O. A., & Cohen, B. A. (2004) · The Clinical Neuropsychologist · doi:10.1080/1385404049052420 · Cited by 144
Diamandidou, E., Buzdar, A. U., Smith, T. L., Frye, D., Witjaksono, M. A., & Hortobágyi, G. N. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2722 · Cited by 122
Self-citationMehlsen, M. Y., Pedersen, A. D., Jensen, A. B., & Zachariae, R. H. (2008) · Psycho-Oncology · doi:10.1002/pon.1398 · Cited by 113
Hippocampal brain amines in methotrexate-induced learning and memory deficit
Madhyastha, S., Somayaji, S. N., Rao, M. S. R., Nalini, K., & Bairy, L. K. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-135 · Cited by 102
Taxol-induced neuropathy: chronic effects of local injection
Röyttä, M., & Raine, C. S. (1986) · Journal of Neurocytology · doi:10.1007/bf01611731 · Cited by 81
Ouimet, L. A., Stewart, A., Collins, B., Schindler, D. C., & Bielajew, C. (2009) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390801992725 · Cited by 81
Clinical, toxicological and pharmaceutical aspects of the antineoplastic drug taxol: A review
Guchelaar, H., ten Napel, C. H. H., de Vries, E. G. E., & Mulder, N. H. (1994) · Clinical Oncology · doi:10.1016/s0936-6555(05)80367-x · Cited by 77
5-Fluorouracil-induced leukoencephalopathy in patients with breast cancer
Choi, S. M., Lee, S., Yang, Y. S., Kim, B. C., Kim, M. K., & Cho, K. H. (2001) · Journal of Korean Medical Science · doi:10.3346/jkms.2001.16.3.328 · Cited by 76
A novel electrophysiological model of chemotherapy-induced cognitive impairments in mice
Gandal, M. J., Ehrlichman, R. S., Rudnick, N. D., & Siegel, S. J. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.060 · Cited by 71
Transient encephalopathy after paclitaxel (Taxol) infusion
Perry, J., & Warner, E. (1996) · Neurology · doi:10.1212/wnl.46.6.1596 · Cited by 61
Akiba, T., Okeda, R., & Tajima, T. (1996) · Acta Neuropathologica · doi:10.1007/s004010050482 · Cited by 54
Li, C.-Q., Liu, D., Huang, L., Wang, H., Zhang, J.-Y., & Luo, X. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.07.010 · Cited by 38
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70294-1 · Cited by 998
Self-citationPrevalence, mechanisms, and management of cancer-related cognitive impairment
Janelsins, M. C., Kesler, S. R., Ahles, T. A., & Morrow, G. R. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.864260 · Cited by 745
Cancer- and Cancer Treatment–Associated Cognitive Change: An Update on the State of the Science
Ahles, T. A., Root, J. C., & Ryan, E. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.0116 · Cited by 704
Koppelmans, V., Breteler, M. M. B., Boogerd, W., Seynaeve, C., Gundy, C., & Schagen, S. B. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.0189 · Cited by 556
Metadata
- Authors
- Wefel, J. S., Saleeba, A. K., Buzdar, A. U., & Meyers, C. A.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2010-04-28
- Volume
- 116
- Issue
- 14
- Pages
- 3348-3356
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2009934258
- Cited by
- 513
- References
- 47
- FWCI
- 24.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.